Cargando…
Recent Advances in Intra-peritoneal Chemotherapy for Gastric Cancer
Peritoneal metastasis (PM) frequently occurs in patients with gastric cancer (GC) and confers a dismal prognosis despite advances in systemic chemotherapy. While systemic chemotherapy has poor peritoneal penetration, intraperitoneal (IP) chemotherapy remains sequestered, resulting in high peritoneal...
Autores principales: | Chia, Daryl K.A., So, Jimmy B.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Gastric Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311211/ https://www.ncbi.nlm.nih.gov/pubmed/32595996 http://dx.doi.org/10.5230/jgc.2020.20.e15 |
Ejemplares similares
-
Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
por: Gwee, Yong Xiang, et al.
Publicado: (2022) -
Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Shree, Venkatesan, et al.
Publicado: (2020) -
The role of Pressurized IntraPeritoneal Aerosol Chemotherapy in the management of gastric cancer: A systematic review
por: Garg, Pankaj Kumar, et al.
Publicado: (2019) -
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
por: Guardiola, Emmanuel, et al.
Publicado: (2009) -
Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer
por: Feldbrügge, Linda, et al.
Publicado: (2021)